European Pharmaceutical Review

FEBRUARY 2, 2023

There is now a large regional concentration in the production of generic APIs in Asia with 66 percent of the world’s API production by volume manufactured in India and China. References European Commission Staff Working Document ‘Strategic Dependencies and Capabilities’, update to the 2020 New Industrial Strategy, 2021.

Generic Medicine 111

Generic Medicine Packaging Documentation Pharmaceutical Companies 111

Pharma in Brief

JUNE 21, 2020

The revised Guidelines outline new price tests for existing and new patented medicines, as well as a revised risk-based system for reporting and investigations. Amendments to the Patented Medicines Regulations are scheduled to come into force on January 1, 2021. They will be available for public comment until July 20, 2020.

Biosimilars 40

Biosimilars Generic Medicine Dosage Documentation 40

Quality Matters

JANUARY 23, 2023

Leveraging insights from data on USP standards distribution and usage at more than 22,000 locations worldwide and 40+ external data sets, USP launched the Medicine Supply Map in 2021 to provide an early-warning capability for supply chain vulnerabilities.

Generic Medicine 52

Generic Medicine Pharmaceutical Manufacturing Biosimilars Communication 52

Quality Matters

MAY 22, 2023

USP’s work in this area includes development of an early-warning capability for potential disruptions in the upstream medicines supply chain. Known as the USP Medicine Supply Map and launched in 2021, this capability leverages more than 250 million data points spanning 92% of generic medicines approved in the U.S.

Generic Medicine 52

Generic Medicine Chemotherapy 52

Quality Matters

OCTOBER 24, 2023

is facing a shortage of medicines that have been the backbone of cancer treatment plans for decades. increased nearly 30% from 2021 and 2022, marking the highest level of shortages in five years, according to data from the American Society of Health-System Pharmacists. While novel cancer therapies offer hope to patients, the U.S.

Hospitals 52

Hospitals Generic Medicine Chemotherapy 52

Quality Matters

JUNE 26, 2023

Complex generics: Are global regulators addressing the needs? The development of generic versions of innovator medicines is a global public health need.

Dosage 52

Dosage Generic Medicine Labelling 52

Quality Matters

APRIL 26, 2023

USP’s work in this area includes development of an early-warning capability for potential disruptions in the upstream medicines supply chain. in a platform that assesses the vulnerability of specific medicines to supply chain disruptions.

Prescription Filling 52

Prescription Filling Generic Medicine Packaging Labelling 52

Pharmaceutical Technology

DECEMBER 19, 2022

Joy Polefrone, the executive director of the organization, says it aims to build a cluster of partners who are capable of manufacturing generic medicines. 2021 was a year of continued innovation and change in the Biopharmaceutical industry. million as part of the Build Back Better Regional Challenge. Free Report.

Pharmaceutical Companies 69

Pharmaceutical Companies Pharmaceutical Companies Pharmaceutical Manufacturing Generic Medicine 69

pharmaphorum

DECEMBER 15, 2020

“Now more than ever, it is our responsibility as a sector to ensure affordable access to healthcare and enable the future longevity of medicine development and supply.”. The generics medicines sector can, too, play a substantial part in discovering new areas for licensed products to be used in. Delivery of essential medicines.

Generic Medicine 93

Generic Medicine Pharmaceutical Companies Pharmaceutical Companies Vaccines 93

pharmaphorum

JUNE 22, 2022

The pharmaceutical industry is no different, with India and China becoming two of the leading manufacturers and exporters of generic medicine, as well as medical supplies, antibiotics and ingredients required to manufacture treatments.

Generic Medicine 114

Generic Medicine Vaccines 114

Express Pharma

JULY 3, 2023

In October of 2021, Waters and Sartorius began a collaboration to help bioprocess scientists accelerate clone selection and process development with new tools for testing and measuring the product quality of recombinant drug products produced in a multi-parallel bioreactor. How poised are you to leverage them?

Biosimilars 95

Biosimilars Drug Development Generic Medicine Immunity 95

Express Pharma

NOVEMBER 1, 2024

The National Policy for Rare Diseases (2021) currently offers financial support of up to Rs 20 lakhs (~$24,000) for treatments, but this should be expanded to include all repurposed drugs with proven efficacy,” he adds. As the world’s largest manufacturer of generic medicines, India has vast potential to utilise repurposed drugs.

Drug Development 111

Drug Development Compounding Generic Medicine Vaccines 111

Quality Matters

APRIL 20, 2023

Launched in 2021 and composed of more than 250 million data points spanning 92% of generic medicines approved in the U.S.,

Biosimilars 52

Biosimilars Labelling Vaccines Generic Medicine 52

Quality Matters

OCTOBER 13, 2021

With this extensive system in place, patients can trust that medicines with the same name will be consistent in quality no matter who manufactures it or where in the world it is made. Since manufacturers know the precise quality specifications, standards help make the approval process for generic medicines more efficient.

Pharmaceutical Manufacturing 52

Pharmaceutical Manufacturing Adverse Reactions Prescription Filling Compounding 52

Express Pharma

SEPTEMBER 11, 2023

This move unburdened the private pharma companies allowing them to concentrate and strengthen their base, and they succeeded in gaining a national as well as international market presence as “global generic medicine manufacturers.” Prices of brands are paradoxically high Pharma contributes 43.2

Generic Medicine 69

Generic Medicine Immunity Immunization Diabetes 69